Investigating long COVID
Join Emma Wall, a Senior Clinical Research Fellow at the Crick as she explains the science of long COVID, who it affects, its symptoms and how it can be prevented and treated.
Long COVID has affected up to 2% of the entire UK population in the last five years, but we still don’t fully understand this often-debilitating disease.
Emma explains how researchers are finding treatments for this new disease and how it’s important to embrace uncertainty to find solutions.
Emma Wall leads clinical research for the UCLH-Crick partnership on COVID-19. Her team are focused on improving understanding of the biology of long COVID to discover new ways to both prevent and treat this complex disease.
Emma has been researching complex infections since first working in Australia and Uganda as a junior doctor, leading to a four-year PhD at the Malawi-Liverpool-Wellcome Trust clinical research programme in Malawi, Southern Africa, before moving to UCL and then the Crick as a post-doctoral clinical researcher. She is also a consultant in Infectious Diseases at UCLH, where she has been treating patients in the long COVID clinic since 2020. Outside of the lab, Emma enjoys running, gardening, cooking, playing the piano and hanging out with her family and friends.
Crick Crash Courses are talks for Crick staff, to help everyone working here – scientists and non-scientists – better understand the Crick's discovery research into how life works. The talks are simple and accessible lectures introducing a topic related to Crick science.
We've now opened our doors to our Crash Course talks, giving everyone, everywhere the opportunity to hear directly from our scientists as they investigate some of the most complex challenges in human health.
